+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Should aspirin be used for the primary prevention of cardiovascular disease in the general population?



Should aspirin be used for the primary prevention of cardiovascular disease in the general population?



Medical Principles and Practice 24(2): 198




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055763290

Download citation: RISBibTeXText

PMID: 25377538

DOI: 10.1159/000368361


Related references

From clinical trials to the general population Use of aspirin in the prevention of cardiovascular disease. American Journal of Epidemiology 153(11 Suppl.): S63, June 1, 2001

Prevalence and population characteristics of aspirin use in the primary and secondary prevention of cardiovascular disease. American Journal of Epidemiology 141(11 Suppl. ): S71, 1995

Epidemiological feasibility of cardiovascular primary prevention in general practice: a trial of vitamin E and aspirin. Collaborative group of the Primary Prevention Project. Journal of Cardiovascular Risk 2(2): 137-142, 1995

Are the benefits of aspirin likely to exceed the risk of major bleeds among people in whom aspirin is recommended for the primary prevention of cardiovascular disease?. New Zealand Medical Journal 131(1484): 19-25, 2018

The Effects of Different Aspirin Dosing Frequencies and the Timing of Aspirin Intake in Primary and Secondary Prevention of Cardiovascular Disease: A Systematic Review. Clinical Pharmacology and Therapeutics 100(5): 500-512, 2016

Investigating the effectiveness of different aspirin dosing regimens and the timing of aspirin intake in primary and secondary prevention of cardiovascular disease: protocol for a systematic review. Systematic Reviews 4: 88, 2016

Aspirin reduces cardiovascular events in primary prevention of cardiovascular disease but at a near equivalent risk of increased bleeding. Evidence-Based Medicine 21(6): 225, 2016

Long-term, low-dose aspirin was effective in the primary prevention of cardiovascular events in general practice. Evidence-Based Cardiovascular Medicine 5(4): 150-151, 2001

Aspirin in the primary prevention of cardiovascular disease. Cardiology Clinics 12(3): 443-450, 1994

Aspirin in the primary prevention of cardiovascular disease. Maturitas 68(1): 3-4, 2011

Don't use aspirin for primary prevention of cardiovascular disease. BMJ 340: C1805, 2010

The Use of Aspirin in Primary Prevention of Cardiovascular Disease. Irish Medical Journal 109(3): 368, 2016

Aspirin for primary cardiovascular disease prevention: what we know and what we don't know. Internal Medicine Journal 49(1): 12-14, 2019

Aspirin for primary prevention of cardiovascular disease. Thrombosis Journal 13: 38, 2015

Aspirin for primary prevention of cardiovascular disease. Medical Letter on Drugs and Therapeutics 42(1072): 18-18, 2000